Individual and composite study endpoints: Separating the wheat from the chaff

American Journal of Medicine

Volumn 127, Issue 5, 2014, Pages 379-384

  Goldberg, Robert ^a,b   Gore, Joel M ^a   Barton, Bruce ^a   Gurwitz, Jerry ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Clinical epidemiology; Study design; Study outcomes and endpoints

Indexed keywords

CLINICAL EPIDEMIOLOGY; STUDY DESIGN; STUDY OUTCOMES AND ENDPOINTS;

CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; ENDPOINT DETERMINATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RESEARCH DESIGN; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84899419687     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.01.011     Document Type: Review

References (32)

1. C.B. Begg, M.K. Cho, and S. Eastwood et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement JAMA 276 1996 637 639
2. R. Collins, and S. MacMahon Reliable assessment of the effects of treatment on mortality and major morbidity, I: Clinical trials Lancet 357 2001 373 380
3. D. Moher, K.F. Schulz, and D.G. Altman The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials Lancet 357 2001 1191 1194
4. S.R. Tunis, D.B. Stryer, and C.M. Clancy Practical clinical trials. Increasing the value of clinical research for decision making in clinical and health policy JAMA 290 2003 1624 1632
5. S.J. Head, S. Kaul, A.J. Bogers, and A.P. Kappetein Non-inferiority study design: lessons to be learned from cardiovascular trials Eur Heart J 33 2012 1318 1324
6. H. Bueno, P.W. Armstrong, and M.J. Buxton et al. The future of clinical trials in secondary prevention after acute coronary syndromes Eur Heart J 32 2011 1583 1589
7. M.S. Conte, P.J. Geraghty, and A.W. Bradbury et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia J Vasc Surg 50 2009 1462 1473
8. S.J. Pocock, C.A. Ariti, T.J. Collier, and D. Wang The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities Eur Heart J 33 2012 176 182
9. H. Bueno, P.W. Armstrong, and M.J. Buxton et al. Cardiovascular round table clinical trials ThinkTank participants. The future of clinical trials in secondary prevention after acute coronary syndromes Eur Heart J 32 2011 1583 1589
10. R.L. Tannen, M.G. Weiner, and D. Xie Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomized controlled trial findings BMJ 338 2009 b81
11. US Department of Health and Human Services, Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims; 2009. Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed December 8, 2011.
12. N.E. Rothrock, N.E. Hays, and R.D. Hays et al. Relative to the general U.S. population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) J Clin Epidemiol 63 2010 1195 1204
13. Patient Centered Outcomes Research Institute. Available at: www.pcori.org. Accessed March 1, 2014.
14. W.W. Busse, W.J. Morgan, V. Taggart, and A. Togias Asthma outcomes workshop: overview J Allergy Clin Immunol 129 3 Suppl 2012 S1 S8
15. R.C. Gershan, M.V. Wagster, and H.C. Hendrie et al. NIH toolbox for assessment of neurological and behavioral function Neurology 80 2013 52 56
16. K.F. Schulz, D.G. Altman, D. Moher CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials PLoS Med 7 2010 e1000251
17. R.V. Luepker, J.M. Raczynski, and S. Osganian et al. Effect of a community intervention on patient delay and emergency medical services use in acute coronary heart disease: the Rapid Early Action for Coronary Treatment (REACT) Trial JAMA 284 2000 60 67
18. K.E. Kip, K. Hollabaugh, O.C. Marroquin, and D.O. Williams The problem with composite end points in cardiovascular studies. The story of major adverse cardiac events and percutaneous coronary intervention J Am Coll Cardiol 51 2008 701 707
19. S. Cicala, G. de Simone, and E. Gerdts et al. Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The losartan intervention for endpoint reduction in hypertension study J Hypertens 28 2010 1134 1140
20. I. Ferreira-González, G. Permanyer-Miralda, and J.W. Busse et al. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns J Clin Epidemiol 60 2007 651 657
21. I. Ferreira- González, J.W. Busse, and D. Heels-Ansdell et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials BMJ 334 7597 2007 786
22. G. Cordoba, L. Schwartz, S. Woloshin, H. Bae, and P.C. Gøtzsche Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review BMJ 341 2010 c3920
23. G.R. D'Haens, R. Fedorak, and M. Lémann IOIBD Membership Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's Disease Inflamm Bowel Dis 15 10 2009 1599 1604
24. M.M. Cloutier, M. Schatz, and M. Castro et al. Asthma outcomes: composite scores of asthma control J Allergy Clin Immunol 129 3 Suppl 2012 S24 S33
25. P.S. Myles, and P.J. Deveraux Pros and cons of composite endpoints in anesthesia trials Anesthesiology 113 2010 776 778
26. Working Group on Health Outcomes for Older Persons with Multiple Chronic Conditions Universal health outcome measures for older persons with multiple chronic conditions J Am Geriatr Soc 60 12 2012 2333 2341
27. J.A. Bakal, C.M. Westerhout, and W.J. Cantor et al. Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpoint Eur Heart J 34 2013 903 908
28. Steering Committee of the Physicians' Health Study Research Group Final report on the aspirin component of the ongoing physicians' health study N Engl J Med 321 1989 129 135
29. D.M. Fisher Surrogate outcomes: meaningful not! Anesthesiology 90 1999 355 356
30. A.L. Olson, J.J. Swigris, and K.K. Brown Clinical trials and tribulations - lessons from pulmonary fibrosis Q J Med 105 2012 1043 1047
31. S. Svensson, D.B. Menkes, and J. Lexchin Surrogate outcomes in clinical trials. A cautionary tale JAMA Intern Med 173 2013 611 612
32. J. Avorn Approval of a tuberculosis drug based on a paradoxical surrogate measure JAMA 309 2013 1349 1350